2131803-93-3 Usage
Molecular Structure
2-((4,4-dimethyl-1-oxothiochroman-6-yl)ethynyl)pyrimidin-5-carboxylic acid features a complex structure with a pyrimidine ring and a carboxylic acid group, along with a thiochroman ring, a methyl group, and an oxo group.
Pyrimidine Ring
The presence of a pyrimidine ring indicates a possible base-like property, which is common in many biologically active compounds and could be relevant in pharmacology.
Carboxylic Acid Group
The carboxylic acid group (-COOH) provides the compound with acidic properties, which can form hydrogen bonds and participate in various chemical reactions.
Thiochroman Ring
The thiochroman ring, containing sulfur, suggests potential differences in reactivity and properties compared to an equivalent oxygen-containing chroman ring.
Methyl and Oxo Groups
The presence of a methyl (-CH3) group contributes to the lipophilicity of the molecule, while the oxo (=O) group may influence the electronic properties and reactivity of the compound.
Potential Applications
This chemical may have potential applications in pharmacology or material science due to its complex structure and various functional groups.
Need for Further Research
Further research and analysis are required to fully understand the properties and potential uses of 2-((4,4-dimethyl-1-oxothiochroman-6-yl)ethynyl)pyrimidin-5-carboxylic acid, as its complex structure may lead to unique interactions and reactivity.
Check Digit Verification of cas no
The CAS Registry Mumber 2131803-93-3 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 2,1,3,1,8,0 and 3 respectively; the second part has 2 digits, 9 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 2131803-93:
(9*2)+(8*1)+(7*3)+(6*1)+(5*8)+(4*0)+(3*3)+(2*9)+(1*3)=123
123 % 10 = 3
So 2131803-93-3 is a valid CAS Registry Number.
2131803-93-3Relevant articles and documents
RETINOID COMPOUND, PREPARATION METHOD THEREFOR, INTERMEDIATES THEREOF AND APPLICATION THEREOF
-
Paragraph 0104; 0105, (2019/01/29)
Disclosed are a retinoid compound, a preparation method therefor, intermediates thereof and an application thereof. The retinoid compound I of the present invention has a good tumor growth inhibition rate.
